These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8896785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bipolar switching after carbamazepine withdrawal.
    Lange-Asschenfeldt C, Blaeser I, Supprian T.
    Pharmacopsychiatry; 2007 Mar; 40(2):86-7. PubMed ID: 17447183
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V, O'Dowd MA, Asnis GM.
    J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract] [Full Text] [Related]

  • 5. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006 Apr; 18 Suppl 1():9-14. PubMed ID: 16754406
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of bipolar depression.
    Dubovsky SL.
    Psychiatr Clin North Am; 2005 Jun; 28(2):349-70, vii. PubMed ID: 15826736
    [Abstract] [Full Text] [Related]

  • 8. On being bipolar without being bipolar.
    Goldberg J.
    J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
    [No Abstract] [Full Text] [Related]

  • 9. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H, Dalal PK, Allet L, Janca A.
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract] [Full Text] [Related]

  • 10. Bipolar disorder.
    Belmaker RH.
    N Engl J Med; 2004 Jul 29; 351(5):476-86. PubMed ID: 15282355
    [No Abstract] [Full Text] [Related]

  • 11. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov 29; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
    Tsouli S, Maranis S, Kyritsis AP.
    Psychiatry Clin Neurosci; 2011 Feb 29; 65(1):112. PubMed ID: 21265947
    [No Abstract] [Full Text] [Related]

  • 18. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH, Choi SW, Joe SH, Ha TH, Yoo HJ, Choi JE, Cha B, Ha K.
    Nord J Psychiatry; 2008 Feb 29; 62(6):496-502. PubMed ID: 18841509
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of oxcarbazepine in bipolar disorder.
    Mazza M, Bria P, Mazza S.
    Can J Psychiatry; 2007 Apr 29; 52(4):272; author reply 272-3. PubMed ID: 17500309
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.